SUBSCRIBE
SUBSCRIBE

Spero Therapeutics

NEWS
Genetown
SEC Filings Reveal GlaxoSmithKline’s 13% Stake in This Massachusetts Biotech
A filing with the SEC indicates that Glaxo now has a 13 percent stake in Spero Therapeutics.
November 17, 2017
 · 
3 min read
 · 
Mark Terry
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Genetown
Backed by Google, Cambridge’s Spero Nabs $51.7 Million Series C
March 8, 2017
 · 
2 min read
Business
Top 20 Life Science Startups to Watch in the U.S.
BioSpace is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the United States.
January 26, 2016
 · 
15 min read
 · 
Mark Terry
What You Need to Know About Spero
Business
What You Need to Know About Spero
December 2, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Merck & Co., New England Patriots Owner Wager $30 Million on Cambridge Startup, Spero
June 8, 2015
 · 
4 min read
Load More
AWARDS
  • NextGen Class of 2016
JOBS
IN THE PRESS
Drug Development
Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
February 28, 2024
 · 
7 min read
Genetown
Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference
February 26, 2024
 · 
4 min read
Genetown
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 31, 2024
January 31, 2024
 · 
2 min read
Genetown
Spero Therapeutics Provides Corporate Update and 2024 Outlook
January 5, 2024
 · 
7 min read
Drug Development
Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections
January 2, 2024
 · 
7 min read
Business
Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update
November 13, 2023
 · 
14 min read
Business
Spero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
November 6, 2023
 · 
1 min read
Genetown
Spero Therapeutics to Present at Upcoming November 2023 Investor Conferences
November 1, 2023
 · 
4 min read
Business
Spero Therapeutics Appoints Esther Rajavelu as Chief Financial Officer and Chief Business Officer
November 1, 2023
 · 
7 min read
Genetown
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 31, 2023
October 31, 2023
 · 
2 min read
Load More